The emergence of missense mutations can abrogate the tumor-suppressive function of wild-type p53 (wtp53), because the mutations in the DBD prevent mutant p53 (mtp53) from binding to the p53-responsive DNA elements on the target gene promoter. This evidence concerns the gene TP53 and neoplasm.